Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term P-Glycoprotein. Found 6 abstracts

Ding PR, Tiwari AK, Ohnuma S, Lee JW, An X, Dai CL, Lu QS, Singh S, Yang DH, Talele TT, Ambudkar SV, Chen ZS. The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter. PLoS One. 2011 Jan;6(4):e19329.   PMCID: PMC3084276
Hudes G. Boosting bioavailability of topotecan: what do we gain?. J Clin Oncol. 2002 Jul;20(13):2918-9.
Takahashi N, Li W, Banerjee D, Guan Y, Wada-Takahashi Y, Brennan MF, Chou TC, Scotto KW, Bertino JR. Sequence-dependent synergistic cytotoxicity of ET-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo. Cancer Res. 2002 Dec;62(23):6909-15.
Chen ZS, Aoki S, Komatsu M, Ueda K, Sumizawa T, Furukawa T, Okumura H, Ren XQ, Belinsky MG, Lee K, Kruh GD, Kobayashi M, Akiyama S. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function. International journal of cancer. 2001 Jul;93(1):107-13.
Johnson RA, Ince TA, Scotto KW. Transcriptional repression by p53 through direct binding to a novel DNA element. The Journal of biological chemistry. 2001 Jul 20;276(29):27716-20.
Zeng H, Liu G, Rea PA, Kruh GD. Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 2000 Sep;60(17):4779-84.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term P-Glycoprotein

metabolism P-Glycoprotein Human pharmacology drug effects US Gov't Support-PHS pharmacokinetics Non-US Gov't Support Breast Neoplasms administration & dosage Adenosine Triphosphate Cultured Tumor Cells Neoplasm Drug Resistance Multiple Drug Resistance Antineoplastic Agents chemistry KB Cells Cell Membrane Doxorubicin drug therapy antagonists & inhibitors Female ATP-Binding Cassette Transporters Isoquinolines Sterols Enzyme Inhibitors Dioxoles Substrate Specificity Topotecan Nude Mice Carrier Proteins Protein Conformation Base Sequence Drug Administration Schedule Paclitaxel Carbon Radioisotopes Carbolines Protein Binding Genetic Transcription physiology genetics Type 5 Cyclic Nucleotide Phosphodiesterases analogs & derivatives Imidazoles biosynthesis Neoplasm Proteins Protein p53 Repressor Proteins Gene Expression Regulation Biological Availability Acridines Estradiol Triazines Leukotriene C4 Intestinal Absorption Mitosis Drug Synergism Inhibitory Concentration 50 Neoplastic Gene Expression Regulation Oral Administration Animal Comparative Study Biological Transport Cell Survival Colchicine Sulfones Osmosis Methotrexate Recombinant Proteins US Gov't Support-Non-PHS Fluorouracil Xenograft Model Antitumor Assays Apoptosis DNA Antineoplastic Combined Chemotherapy Protocols Camptothecin Tritium Vincristine toxicity Phosphodiesterase 5 Inhibitors Cisplatin Anion Transport Proteins Adenosine Triphosphatases Molecular Models Active Biological Transport DNA Primers Marine Toxins Etoposide Cell Line Type I DNA Topoisomerases pathology Kidney Glutathione Glycocholic Acid Binding Sites Mice Kinetics Piperazines
Last updated on Thursday, August 13, 2020